Skip to main content

Table 5 Cardio-metabolic risk factors and biomarkers of the study participants by self rated health status

From: Self-Rated Health in middle-aged and elderly Chinese: distribution, determinants and associations with cardio-metabolic risk factors

Variable, mean (SD)

Total

(n = 3289)

Good

(n = 1051)

Fair

(n = 1733)

Poor

(n = 503)

PValue#

Resistin

11.45(9.36)

11.03(9.44)

11.42(8.62)

12.49(11.37)

0.01208*

PAI-1

14.72(18.13)

13.31(17.45)

15.80(18.67)

13.83(17.21)

< 0.0001*

RBP4

40.1(11.75)

39.05(11.39)

40.74(11.84)

40.08(12.05)

0.0014*

Adipo

16.50(11.65)

16.06(11.49)

16.50(11.51)

17.41(12.38)

0.252

IL-6

1.55(2.77)

1.49(2.52)

1.45(2.29)

2.02(4.30)

0.0003*

CRP

1.57(4.29)

1.23(2.12)

1.66(5.22)

1.97(4.06)

< 0.0001*

Insulin

15.44(9.48)

14.27(9.13)

15.67(8.40)

17.12(12.83)

< 0.0001*

Homa-ir

4.09(3.35)

3.61(2.66)

4.18(3.08)

4.78(5.03)

< 0.0001*

Homa2-ir

0.30(0.22)

0.28(0.26)

0.31(0.17)

0.34(0.27)

< 0.0001*

SBP

140.12(22.47)

138.62(22.13)

139.72(22.36)

144.66(23.04)

< 0.0001*

DBP

80.17(10.80)

79.69(10.38)

80.05(11.02)

81.56(10.83)

< 0.005*

HDL

1.28(0.33)

1.31(0.34)

1.26(0.33)

1.27(0.34)

< 0.0018*

LDL

3.26(0.97)

3.14(0.94)

3.33(0.97)

3.28(1.00)

< 0.0001*

TCH

4.70(0.98)

4.58(0.94)

4.76(0.98)

4.71(1.03)

< 0.0001*

TG

1.39(1.07)

1.24(0.92)

1.48(1.17)

1.39(0.96)

< 0.0001*

  1. Abbreviations: PAI_1, plasminogen activator inhibitor-1; RBP4, retinol binding protein 4; ADIPO, adiponectin; IL6, interleukin-6; IL6, interleukin-6; CRP, c-reactive protein; Homa-ir, homeostasis model assessment of insulin resistance (fasting glucose (mmol/L) × fasting insulin (μU/ml)/22.5); SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TCH, total cholesterol; TG, triglycerides; SD, standard deviation;
  2. # Wilcoxon/t-test p-value that indicates the difference of the levels of biomarkers within the levels of SRH; *P < 0.05